• Explore /
  • Poster
  • / A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non–small cell lung cancer (NSCLC) (RAMP 203).

A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non–small cell lung cancer (NSCLC) (RAMP 203).

Abstract Poster

Authors

null

Ramaswamy Govindan

Washington University School of Medicine, St. Louis, MO

Ramaswamy Govindan , Mark M. Awad , Shirish M. Gadgeel , Jonathan A. Pachter , Gloria Patrick , Louis J. Denis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT05074810

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS9148)

DOI

10.1200/JCO.2022.40.16_suppl.TPS9148

Abstract #

TPS9148

Poster Bd #

128b

Abstract Disclosures

Similar Posters

First Author: Joshua E. Reuss

First Author: Amir Noeparast

First Author: Samuel John Harris

First Author: Celine Yeh